A Study to Investigate the Comparative Effectiveness of Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
Terminated
- Conditions
- Chronic Graft vs Host Disease
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 15
- Registration Number
- NCT04852692
- Locations
- 🇰🇷
The Catholic University of Korea Seoul St Mary s Hospital, Seoul, Korea, Republic of
🇰🇷Soonchunhyang University Bucheon Hospital, Bucheon-Si, Korea, Republic of
🇰🇷Pusan National University Hospital, Busan, Korea, Republic of
A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 30
- Registration Number
- NCT04230252
- Locations
- 🇰🇷
H plus Yangji Hospital, Seoul, Korea, Republic of
A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants
- First Posted Date
- 2020-01-02
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 30
- Registration Number
- NCT04214691
- Locations
- 🇰🇷
H plus Yangji Hospital, Seoul, Korea, Republic of
Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
- First Posted Date
- 2019-05-08
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 685
- Registration Number
- NCT03942120
- Locations
- 🇰🇷
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, Korea, Republic of
🇰🇷GyeongSang National University Hospital, Jinju, Korea, Republic of
🇰🇷Bucheon Soonchunhyang Hospital, Kyunggido, Korea, Republic of
A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2019-10-17
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 33
- Registration Number
- NCT02505568
Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
- First Posted Date
- 2015-06-17
- Last Posted Date
- 2015-06-30
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 171
- Registration Number
- NCT02474563
Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Completed
- Conditions
- Colitis, Ulcerative
- Interventions
- Other: No Intervention
- First Posted Date
- 2014-09-01
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 368
- Registration Number
- NCT02229344
Bioequivalence Test for Risperdal 2mg of Janssen Korea
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2013-12-16
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 36
- Registration Number
- NCT02012049
An Observational Study to Evaluate the Quality of Life in Korean Female Participants With Chronic Constipation
Completed
- Conditions
- Constipation
- Interventions
- Drug: Prucalopride; observational study
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 150
- Registration Number
- NCT01902537
Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain
Phase 4
Completed
- Conditions
- Chronic Pain
- Interventions
- Drug: Fentanyl-TTS
- First Posted Date
- 2013-07-18
- Last Posted Date
- 2014-08-28
- Lead Sponsor
- Janssen Korea, Ltd., Korea
- Target Recruit Count
- 65
- Registration Number
- NCT01902524
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath